Mirum will now await results from its second Phase III HDV study on brelovitug Mirum Pharmaceuticals has secured a positive outcome for the first late-stage trial on its chronic hepatitis delta virus ...
Ask any Baldur’s Gate 3 player about the game’s Act 2, and you’ll get one of two reactions. Some call it their favorite stretch of the game, since it’s moodier, tighter, and more focused than Act 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results